controversy over which ORAL anticoagulant to use to prevent strokes in patients with atrial fibrillation

October 2011

You'll hear controversy over which ORAL anticoagulant to use to prevent strokes in patients with atrial fibrillation.

Warfarin was our only option for over 50 years...but you'll soon get questions about how the new ones stack up.

Warfarin is the gold standard. You know its limitations...INR monitoring, dose adjustments, and many drug and food interactions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote